Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.92 USD
Change Today -0.0922 / -4.59%
Volume 9.1K
PFSCF On Other Exchanges
Symbol
Exchange
OTC US
Toronto
Frankfurt
As of 8:10 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

prometic life sciences inc (PFSCF) Snapshot

Open
$1.94
Previous Close
$2.01
Day High
$1.94
Day Low
$1.92
52 Week High
03/19/15 - $2.24
52 Week Low
04/29/14 - $0.79
Market Cap
1.1B
Average Volume 10 Days
14.6K
EPS TTM
--
Shares Outstanding
554.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PROMETIC LIFE SCIENCES INC (PFSCF)

Related News

No related news articles were found.

prometic life sciences inc (PFSCF) Related Businessweek News

No Related Businessweek News Found

prometic life sciences inc (PFSCF) Details

ProMetic Life Sciences Inc., a biopharmaceutical company, develops bioseparation, plasma-derived therapeutics, and small-molecule drugs. The company also offers its technologies for large-scale drug purification, drug development, proteomics, and the elimination of pathogens; and develops small molecule therapeutics products targeting unmet medical needs in the fields of fibrosis, anemia, cancer, and autoimmune disease, as well as plasma-derived therapeutics in orphan drug indications. It operates in two segments, Therapeutics and Protein Technology. The Therapeutics segment’s lead product includes PBI-4050, which targets unmet medical needs, such as the treatment of fibrosis in patients with chronic kidney diseases and certain cancers, and the side effects associated with chemotherapy. This segment also develops PBI-4419, an anti-fibrotic and anti-inflammatory compound for kidney injury and chronic kidney diseases; and PBI-1402, a drug candidate for the treatment of anemia indications. The Protein Technology segment provides plasma protein purification system, a solution for the extraction and purification of therapeutic proteins from human plasma; bioseparation products based on applications of its patented Mimetic Ligand technology for various biopharmaceutical companies; and prion capture/pathogen removal technology platform that improves the safety profile of blood products and blood-derived therapeutics. The company was formerly known as Innovon Life Sciences Holdings Limited and changed its name to ProMetic Life Sciences Inc. in May 1998. ProMetic Life Sciences Inc. was founded in 1992 and is headquartered in Laval, Canada.

Founded in 1992

prometic life sciences inc (PFSCF) Top Compensated Officers

Chief Executive Officer, President and Non-In...
Total Annual Compensation: C$435.0K
Chief Financial Officer and Chief Operating O...
Total Annual Compensation: C$322.3K
Chief Executive Officer of ProMetic BioScienc...
Total Annual Compensation: C$238.5K
General Counsel and Corporate Secretary
Total Annual Compensation: C$197.0K
Senior Vice President of Product & Asia Pacif...
Total Annual Compensation: C$283.6K
Compensation as of Fiscal Year 2013.

prometic life sciences inc (PFSCF) Key Developments

ProMetic Life Sciences Inc.(TSX:PLI) added to S&P/TSX Capped Composite Index

ProMetic Life Sciences Inc.(TSX:PLI) added to S&P/TSX Capped Composite Index

ProMetic Life Sciences Inc.(TSX:PLI) added to S&P/TSX Completion Index

ProMetic Life Sciences Inc.(TSX:PLI) added to S&P/TSX Completion Index

ProMetic Life Sciences Inc.(TSX:PLI) added to S&P/TSX Composite Index

ProMetic Life Sciences Inc.(TSX:PLI) added to S&P/TSX Composite Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFSCF:US $1.92 USD -0.0922

PFSCF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PFSCF.
View Industry Companies
 

Industry Analysis

PFSCF

Industry Average

Valuation PFSCF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 66.5x
Price/Book 39.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 66.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROMETIC LIFE SCIENCES INC, please visit www.prometic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.